Last reviewed · How we verify
NCT06697912
Airway Flow of RAM Cannula With BCPAP in Infants
trial in Respiratory Distress Syndrome, Newborn in 100 participants. Completed in 1 June 2025.
1 June 2025
Quick facts
| Lead sponsor | Karolinska Institutet |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 19 November 2024 |
| Primary completion | 1 June 2025 |
| Estimated completion | 1 June 2025 |
| Sites | 1 location across Vietnam |
Conditions studied
- Respiratory Distress Syndrome, Newborn — all drugs for Respiratory Distress Syndrome, Newborn →
- Infant, Premature, Diseases — all drugs for Infant, Premature, Diseases →
- Infant, Newborn, Diseases — all drugs for Infant, Newborn, Diseases →
Sponsor
Karolinska Institutet
Who can join
Adults 0 Hours to 3 Months, any sex, with Respiratory Distress Syndrome, Newborn or Infant, Premature, Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The RAM Cannula interface is used as routine interface for newborn infants receiving CPAP treatment for respiratory distress. Compared to the standard systems that have been used for more than 50 years, the interface has high resistance and has not been extensively studied. The delivered quality of the CPAP support is likely to be negatively affected by the interface resistance. We hypothesise that exhalations through the device is uncommon and that the interface resistance restricts flow from the patient. If expiratory flows are uncommon the RAM interface provide support clinically comparable to other systems based on unidirectional flow such as humidified high-flow cannula. This is a cross-sectional, observational study (no intervention) in newborn infants that are clinically stable and on respiratory support with the RAM interface connected to a bCPAP circuit. This is the most common support in the Phu San neonatal unit. The time needed for data collection is short and collection is expected to take approximately five minutes (less than 15 minutes) in a quiet infant. The collection can be planned to minimize disturbances for the infant, parents and staff. For example, the busiest times of the day can be avoided to not intervene with daily care, ward rounds or examinations of the infant. Data on flow and pressure will be collected within the respiratory support circuit at the connection to the RAM interface. The measurements are passive, and no tests or manipulation of the infant is planned. There will be brief interruptions (\<1 min) in respiratory support when the meters are connected. Similar interruptions are very common and occurs several times per day during normal care. Data will be collected in case report forms (CRF) with REDCap electronic data capture tool. All personal identifiers will be removed before data export from REDCap and further analysis only using enrolment numbers. Background variables describing the pregnancy, delivery and the infant will be collected. We also will record details of the RAM-cannula interface, such as size, protective dressing, gastric feeding tube, obvious leak at nares and mouth. During the measurement the infant will be monitored for vital signs and any problems will be addressed and recorded. This includes oxygen need, CPAP support and breathing problems. The flow and pressure data for one minute of quiet breathing will be stored locally with the enrolment number as identifier. The analysis after collection of flow and pressure will include average flow in the CPAP circuit, the flow to the patient, average absolute leak and delivered pressure. If a variation with breathing can be seen this will be described. These output variables directly relate to the research questions. 1. What flows and pressure can be observed in the breathing circuit? \[Measured average flows, pressure and variability between patients\] 2. Do infants exhale through the RAM interface? \[Measured expiratory flows at the interface\] 3. What is the level of leak for the interface? \[Measured absolute leak\] The RAM cannula interface has been widely introduced but is not CE-marked for CPAP support. It has an advantage of being more comfortable and light weight with less nasal injury in most trials. The high resistance of the RAM interface has been discussed as problematic by several authors, but the clinical importance is not known. Comparing RAM interface to other CPAP interfaces in clinical trials is difficult and, if RAM has a treatment effect similar to HHFNC, very large trials of high quality would be needed. The described study will generate new knowledge on the RAM interface by describing patient flow through the interface and illustrate the importance of resistance and leak. The study is not strictly a physiological study but investigate flow in an airway interface. The most likely outcome is that exhalation is uncommon, and this would support that the RAM interface has more similarities with HHFNC than conventional CPAP.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06697912
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Respiratory Distress Syndrome, Newborn
Currently open trials in the same condition.
- NCT07344714 — Predicting the Need for Prolonged Respiratory Support in Neonates Delivered in a Lower-Level NICU Setting · recruiting
- NCT07514481 — LISA vs Endotracheal Surfactant in Preterm Neonates: A Lung Ultrasound Distribution Study · NA · recruiting
- NCT06880016 — Evaluation of Serial Lung Ultrasound Data After Surfactant Treatments Applied With Different Methods in Preterm Babies · NA · recruiting
- NCT06007547 — Prophylactic Minimally Invasive Surfactant Evaluation · Phase 4 · recruiting
Other Karolinska Institutet trials
Trials by the same sponsor.
- NCT06359262 — Evaluating the Hope@School Prevention Program · NA · not yet recruiting
- NCT07289490 — Bilateral vs Unilateral Inguinal Hernia Repairs With an Asymptomatic Inguinal Hernia in Bilateral Hernias · NA · not yet recruiting
- NCT06894264 — Emotion Processing and Regulation in People With Intellectual Disability · NA · not yet recruiting
- NCT07494266 — Safety of a Healthy Plant-based Diet With Higher Potassium Content, Compared to a Healthy Plant-based Diet With Limited · NA · not yet recruiting
- NCT07442032 — Cardiovascular Phenotypes in Sepsis · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06697912 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Karolinska Institutet
- Last refreshed: 25 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06697912.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing